Rhythm Pharmaceuticals ( RYTM +2.05%) is another biotech stock (in this case, a mid-cap stock) that I think could easily trounce the market in 2026. Rhythm currently markets only one product, Imcivree …
Prediction: These 3 Stocks Will Crush the Market in 2026
view original post